EUVIMEDEUVIMED entdecken
Crossref

METTL3 promotes the hypertrophic scar fibrosis via m6A RNA methylation of GRAMD1B mRNA

Wanli Guo, Wei Song, Yanbin Zhai, Peiyi Bai, Zhihui Guo, Xiaorui Tian, Peng Duan

Journal of Molecular Histology · 2025

DOI: 10.1007/s10735-025-10475-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular Histology, 2025. Verfasst von Wanli Guo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Burn Department, General Hospital of TISCO (Taiyuan Iron and Steel (Group) Co., Ltd), No. 213 North Street, Xinhualing District, Taiyuan, Shanxi Prov…. Hauptthemen laut MEDLINE: Methyltransferases, Cicatrix, Hypertrophic, RNA, Messenger, Adenosine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: the General Hospital of TISCO.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypertrophic scarring (HS) is a common fibrotic disorder characterized by excessive extracellular matrix deposition and fibroblast proliferation. N6-methyladenosine (m6A) RNA methylation, mediated by METTL3, has emerged as a critical regulator of gene expression and cellular processes. This study investigates the role of METTL3-mediated m6A methylation in hypertrophic scar fibrosis. We found that METTL3 expression and m6A RNA methylation levels were significantly elevated in human hypertrophic scar tissues and TGF-β1-induced human dermal fibroblasts. Silencing METTL3 reduced m6A methylation, impaired fibroblast proliferation, and decreased the mRNA and protein expression of fibrotic markers (ACTA2, Col1a1, Col3a1, and CTGF). Bioinformatics analysis identified GRAMD1B as a key differentially expressed gene in HS tissues. METTL3-mediated m6A methylation enhanced GRAMD1B mRNA stability, promoting its expression. These findings suggest that METTL3 contributes to hypertrophic scar fibrosis by regulating m6A methylation of GRAMD1B mRNA, highlighting METTL3 as a potential therapeutic target for fibrotic disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethyltransferasesCicatrix, HypertrophicRNA, MessengerAdenosineHumansMethylationFibrosisFibroblastsCell ProliferationMaleGene Expression RegulationFemaleRNA Methylation

Stichwörter der Autor:innen

GRAMD1BHypertrophic scar fibrosisMETTL3m6A methylation

Substanzen

MethyltransferasesMETTL3 protein, humanRNA, MessengerAdenosineN-methyladenosine

Autor:innen und Institutionen

  • Burn Department, General Hospital of TISCO (Taiyuan Iron and Steel (Group) Co., Ltd), No. 213 North Street, Xinhualing District, Taiyuan, Shanxi Province, China.
  • Burn Department, General Hospital of TISCO (Taiyuan Iron and Steel (Group) Co., Ltd), No. 213 North Street, Xinhualing District, Taiyuan, Shanxi Province, China. dp661033@163.com.

Förderung

  • the General Hospital of TISCO

Zitieren

APA

Guo, W., Song, W., Zhai, Y., Bai, P., Guo, Z., Tian, X., & Duan, P. (2025). METTL3 promotes the hypertrophic scar fibrosis via m6A RNA methylation of GRAMD1B mRNA. Journal of Molecular Histology. https://doi.org/10.1007/s10735-025-10475-7

Vancouver

Guo W, Song W, Zhai Y, Bai P, Guo Z, Tian X, et al. METTL3 promotes the hypertrophic scar fibrosis via m6A RNA methylation of GRAMD1B mRNA. Journal of Molecular Histology. 2025. doi:10.1007/s10735-025-10475-7

BibTeX
@article{Guo2025,
  author = {Guo, Wanli and Song, Wei and Zhai, Yanbin and Bai, Peiyi and Guo, Zhihui and Tian, Xiaorui and Duan, Peng},
  title = {METTL3 promotes the hypertrophic scar fibrosis via m6A RNA methylation of GRAMD1B mRNA},
  journal = {Journal of Molecular Histology},
  year = {2025},
  doi = {10.1007/s10735-025-10475-7}
}
Kostenlos starten →